Literature DB >> 9703693

Mass spectrometry in the search for uremic toxins.

T Niwa1.   

Abstract

This article reviews the literature on the mass spectrometry (MS) that has been used in the research of uremic toxins. Gas chromatography/mass spectrometry (GC/MS) has been most often used for the analysis of low-molecular-weight compounds in uremic blood such as organic acids, phenols, and polyols. However, it cannot be used for the analysis of middle- to high-molecular-weight substances or for involatile compounds. The development of fast atom bombardment (FAB) and liquid secondary ion mass spectrometry (LSIMS) has made possible the analysis of middle-molecules and involatile low-molecular-weight substances such as peptides and nucleosides. The development of atmospheric pressure chemical ionization (APCI) has also lead to the analysis of involatile low-molecular-weight substances. The recent advances in ionization methods, such as electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI), have permitted the MS analysis of high-molecular-weight substances such as beta 2-microglobulin, a major component of dialysis amyloid. Liquid chromatography/mass spectrometry (LC/MS), using ESI, APCI, or FAB as an ionization method, is currently the preferred method for the analysis of low- to high-molecular-weight substances in uremic blood. ESI-LC/MS and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOFMS) are useful for elucidating the structure of post-translationally modified proteins obtained from the blood and tissues of uremic patients. Post-translational modification such as the formation of advanced glycation end-products and carbamoylation is enhanced in uremic patients, and is considered to be responsible for some uremic symptoms. Laser microprobe MS is unique in its capability for the two-dimensional detection of atoms such as aluminum in a tissue section obtained from uremic patients. This review focuses on the mainstream research for discovering uremic toxins, specific uremic toxins identified or quantified using MS, and the MS analysis of post-translationally modified proteins in uremia. These studies have provided ample evidence that MS has played an important role in the search for uremic toxins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9703693     DOI: 10.1002/(SICI)1098-2787(1997)16:6<307::AID-MAS1>3.0.CO;2-L

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  7 in total

1.  On-line monitoring of solutes in dialysate using wavelength-dependent absorption of ultraviolet radiation.

Authors:  I Fridolin; L G Lindberg
Journal:  Med Biol Eng Comput       Date:  2003-05       Impact factor: 2.602

2.  Rapid determination of advanced glycation end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm.

Authors:  Yinong Zhang; Ross R Cocklin; Keshore R Bidasee; Mu Wang
Journal:  J Biomol Tech       Date:  2003-09

3.  Proteins and their modifications in a medieval mummy.

Authors:  Ivan Mikšík; Pavla Sedláková; Statis Pataridis; Federica Bortolotti; Rossella Gottardo
Journal:  Protein Sci       Date:  2016-09-08       Impact factor: 6.725

4.  Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.

Authors:  Yoshiharu Itoh; Atsuko Ezawa; Kaori Kikuchi; Yoshinari Tsuruta; Toshimitsu Niwa
Journal:  Mass Spectrom (Tokyo)       Date:  2013-04-15

Review 5.  Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells.

Authors:  Maxime Espi; Laetitia Koppe; Denis Fouque; Olivier Thaunat
Journal:  Toxins (Basel)       Date:  2020-05-06       Impact factor: 4.546

6.  Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics.

Authors:  Jessica R Gooding; Shipra Agrawal; Susan McRitchie; Zach Acuff; Michael L Merchant; Jon B Klein; William E Smoyer; Susan J Sumner
Journal:  Kidney Int Rep       Date:  2019-09-19

Review 7.  The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases.

Authors:  Mieke Steenbeke; Reinhart Speeckaert; Stéphanie Desmedt; Griet Glorieux; Joris R Delanghe; Marijn M Speeckaert
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.